Trial Profile
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2009
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin aspart; Insulin lispro
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 14 Apr 2009 New trial record